Conference
Preoperative window-of-opportunity (WOO) study of dacomitinib (Dac) in patients (Pts) with resectable oral cavity squamous cell carcinoma (OCC): Generation of a gene expression signature (DGS) as a predictor of Dac activity.
Authors
Brana I; She D; Chau NG; Pham N-A; Kim L; Sakashita S; Ng C; Zhu C; Razak ARA; Chen E
Volume
32
Pagination
pp. 6041-6041
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2014
DOI
10.1200/jco.2014.32.15_suppl.6041
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X